Home > Financial Ratios > NURECA

NURECA
Core EBITDA Growth

    Back to All Ratios
NURECA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

NURECA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 1,494.46103.88-112.51-1.79559.74

What is the latest Core EBITDA Growth ratio of NURECA ?

The latest Core EBITDA Growth ratio of NURECA is 1,494.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20251,494.46
Mar2024103.88
Mar2023-112.51
Mar2022-1.79
Mar2021559.74

How is Core EBITDA Growth of NURECA Trending?

Years Core EBITDA Growth % Change
Mar2025 1494.46
1,338.64
Mar2024 103.88
Positive
Mar2023 -112.51
Negative
Mar2022 -1.79
Negative
Mar2021 559.74 -

Other Financial Ratios of NURECA


Compare Core EBITDA Growth ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹265.0 Cr -1.1% -4.8% -22.1% Stock Analytics
POLY MEDICURE ₹15,384.8 Cr -4.5% -10.6% -38.3% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

-1.1%

-4.8%

-22.1%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses